Optimize your Research and Development with M&S Decisions
Our mission is to develop Drug-Disease modeling platforms to be used as quantitative tools, in support of decision-making across R&D continuum. It’s important to apply such platforms of quantitative knowledge integration towards real projects. Thus it allows to address recurring questions on compound selection, dose & dose scheduling, therapeutic window, biomarker selection, patient populations and selection, combination therapies and study design optimization.
Kirill Peskov,
Chief Executive Officer
About M&S Decisions
M&S Decisions is a scientific consulting company, founded in May 2015. We use modeling and simulation techniques to support decision making in drug development.
We have expertise in translational science, quantitative systems pharmacology, population modeling, biostatistics and post-marketing research.
We provide and share our experience across the Skolkovo Biomedical cluster building the strong partnership with scientific startups and society.
Our Team
Our team has been working together for more than 5 years and consists of 15 modeling scientists with core scientific expertise in systems pharmacology, pharmacometrics, model-based drug development, data mining and meta-analysis.
Our experience
Our Partners
